Статья

Epidemiology of hospital admissions with influenza during the 2013/2014 Northern hemisphere influenza season: Results from the Global Influenza Hospital Surveillance Network

J. Puig-Barberà, A. Natividad-Sancho, S. Trushakova, A. Sominina, M. Pisareva, M. Ciblak, S. Badur, H. Yu, B. Cowling, G. El, A. Mira-Iglesias, L. Kisteneva, K. Stolyarov, K. Yurtcu, L. Feng, X. López-Labrador, E. Burtseva, V. Afanasieva, F. Aktaş, S. Borekci, A. Buigues-Vila, Z. Buzitskaya, J. Cai, B. Çakir, M. Carballido-Fernández, C. Carratalá-Munuera, C. Chai, E. Chen, S. Çelebi, Y. Cui, D. Deniz, H. Dong, X. Dong, M. Durusu, A. Fadeev, S. Feng, E. Garina, S. Gencer, V. Gil-Guillén, M. Hacimustafaoǧlu, S. Hancerli, L. Huang, D. Ip, L. Kolobukhina, K. Krasnoslobotsev, C. Li, R. Limón-Ramírez, C. Mahé, L. Merkulova, M. Mollar, E. Mukasheva, L. Ozisik, M. Otero-Reigada, S. Özer, Y. Qin, A. Eren-Şensoy, E. Smorodintseva, V. Sukhovetskaya, G. Sun, Y. Tang, A. Tormos, F. López-Labrador, M. Tortajada-Girbés, R. Vartanyan, L. Voloshchuk, Q. Wang, D. Wen, P. Wu, P. Yang, B. Yi, S. Zhang, Y. Zhang, J. Zheng,
2021

Background: The Global Influenza Hospital Surveillance Network was established in 2012 to obtain valid epidemiologic data on hospital admissions with influenza-like illness. Here we describe the epidemiology of admissions with influenza within the Northern Hemisphere sites during the 2013/2014 influenza season, identify risk factors for severe outcomes and complications, and assess the impact of different influenza viruses on clinically relevant outcomes in at-risk populations. Methods: Eligible consecutive admissions were screened for inclusion at 19 hospitals in Russia, Turkey, China, and Spain using a prospective, active surveillance approach. Patients that fulfilled a common case definition were enrolled and epidemiological data were collected. Risk factors for hospitalization with laboratory-confirmed influenza were identified by multivariable logistic regression. Findings: 5303 of 9507 consecutive admissions were included in the analysis. Of these, 1086 were influenza positive (534 A(H3N2), 362 A(H1N1), 130 B/Yamagata lineage, 3 B/Victoria lineage, 40 untyped A, and 18 untyped B). The risk of hospitalization with influenza (adjusted odds ratio [95% confidence interval]) was elevated for patients with cardiovascular disease (1.63 [1.33-2.02]), asthma (2.25 [1.67-3.03]), immunosuppression (2.25 [1.23-4.11]), renal disease (2.11 [1.48-3.01]), liver disease (1.94 [1.18-3.19], autoimmune disease (2.97 [1.58-5.59]), and pregnancy (3.84 [2.48-5.94]). Patients without comorbidities accounted for 60% of admissions with influenza. The need for intensive care or in-hospital death was not significantly different between patients with or without influenza. Influenza vaccination was associated with a lower risk of confirmed influenza (adjusted odds ratio = 0.61 [0.48- 0.77]). Conclusions: Influenza infection was detected among hospital admissions with and without known risk factors. Pregnancy and underlying comorbidity increased the risk of detecting influenza virus in patients hospitalized with influenza-like illness. Our results support influenza vaccination as a measure for reducing the risk of influenza-associated hospital admission. © 2016 Puig-Barberà et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Цитирование

Похожие публикации

Источник

Версии

  • 1. Version of Record от 2021-04-27

Метаданные

Об авторах
  • J. Puig-Barberà
    Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana (FISABIO), Valencia, Spain
  • A. Natividad-Sancho
    D.I. Ivanovsky Institute of Virology FSBI N.F. Gamaleya FRCEM, Ministry of Health of Russian Federation, Moscow, Russian Federation
  • S. Trushakova
    Research Institute of Influenza, St. Petersburg, Russian Federation
  • A. Sominina
    National Influenza Reference Laboratory, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
  • M. Pisareva
    Division of Infectious Disease, Key Laboratory of Surveillance and Early-Warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China
  • M. Ciblak
    School of Public Health, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong
  • S. Badur
    Sanofi Pasteur, Lyon, France
  • H. Yu
    Centro de Investigación Biomédica en Epidemiología y Salud Publica (CIBER-ESP), Instituto de Salud Carlos III, Madrid, Spain
  • B. Cowling
    Faculty of Medicine, Gazi University, Ankara, Turkey
  • G. El
    Cerrahpaşa Faculty of Medicine, Istanbul University, Istanbul, Turkey
  • A. Mira-Iglesias
    FISABIO-Salud Pública, Valencia, Spain
  • L. Kisteneva
    Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China
  • K. Stolyarov
    Department of Public Health, Faculty of Medicine, Hacettepe University, Sihhiye, Ankara, Turkey
  • K. Yurtcu
    Hospital General, Castellón, Spain
  • L. Feng
    Universidad Miguel Hernández, San Juan de Alicante, Spain
  • X. López-Labrador
    Uludaǧ University Faculty of Medicine, Bursa, Turkey
  • E. Burtseva
    Changping District Hospital, Beijing, China
  • V. Afanasieva
    Dr. Siyami Ersek Göǧüs Kalp Ve Damar Cerrahisi Eǧitim ve Araştirma Hastanesi, Istanbul, Turkey
  • F. Aktaş
    Ningbo Center for Diseases Prevention and Control, Ningbo, China
  • S. Borekci
    First Peoples' Hospital of Huzhou, Huzhou, China
  • A. Buigues-Vila
    Hacettepe Üniversitesi, Ankara, Turkey
  • Z. Buzitskaya
    Dr. Lütfi Kirdar Kartal Training and Research Hospital, Istanbul, Turkey
  • J. Cai
    Uludaǧ University, Bursa, Turkey
  • B. Çakir
    Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
  • M. Carballido-Fernández
    Ningbo Women and Children Hospital, Ningbo, China
  • C. Carratalá-Munuera
    Huairou District Center for Diseases Prevention and Control, Beijing, China
  • C. Chai
    Hospital La Plana, Vila-real, Spain
  • E. Chen
    Hospital La Fe, Valencia, Spain
  • S. Çelebi
    Hacettepe University, Ankara, Turkey
  • Y. Cui
    Beijing Huairou Hospital, Beijing, China
  • D. Deniz
    Changping District Center for Diseases Prevention and Control, Beijing, China
  • H. Dong
    Consorcio de Investigación Biomédica de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain
  • X. Dong
    Hospital Dr Peset, Valencia, Spain
  • M. Durusu
    Beijing Center for Disease Prevention and Control, Beijing, China
  • A. Fadeev
    Huzhou Center for Diseases Prevention and Control, Huzhou, China
  • S. Feng
    Third Hospital of Yinzhou District, Ningbo, China
  • E. Garina
  • S. Gencer
  • V. Gil-Guillén
  • M. Hacimustafaoǧlu
  • S. Hancerli
  • L. Huang
  • D. Ip
  • L. Kolobukhina
  • K. Krasnoslobotsev
  • C. Li
  • R. Limón-Ramírez
  • C. Mahé
  • L. Merkulova
  • M. Mollar
  • E. Mukasheva
  • L. Ozisik
  • M. Otero-Reigada
  • S. Özer
  • Y. Qin
  • A. Eren-Şensoy
  • E. Smorodintseva
  • V. Sukhovetskaya
  • G. Sun
  • Y. Tang
  • A. Tormos
  • F. López-Labrador
  • M. Tortajada-Girbés
  • R. Vartanyan
  • L. Voloshchuk
  • Q. Wang
  • D. Wen
  • P. Wu
  • P. Yang
  • B. Yi
  • S. Zhang
  • Y. Zhang
  • J. Zheng
Название журнала
  • PLoS ONE
Том
  • 11
Выпуск
  • 5
Страницы
  • -
Ключевые слова
  • influenza vaccine; adolescent; adult; aged; Article; asthma; autoimmune disease; cardiovascular disease; child; China; comorbidity; controlled study; disease surveillance; epidemiological data; female; flu like syndrome; hospital admission; hospital mortality; hospitalization; human; immune deficiency; infant; infection risk; influenza; influenza A (H1N1); influenza A (H3N2); influenza B; influenza vaccination; Influenza virus; intensive care; kidney disease; liver disease; major clinical study; male; middle aged; newborn; nonhuman; Northern Hemisphere; pregnancy; preschool child; prospective study; risk factor; risk reduction; Russian Federation; Spain; Turkey (republic); very elderly; clinical trial; cluster analysis; epidemiological monitoring; hospital admission; Influenza, Human; multicenter study; multivariate analysis; odds ratio; Orthomyxoviridae; outcome assessment; pregnancy complication; risk; Turkey; young adult; Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; China; Cluster Analysis; Comorbidity; Epidemiological Monitoring; Female; Humans; Infant; Infant, Newborn; Influenza, Human; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Orthomyxoviridae; Outcome Assessment (Health Care); Patient Admission; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Risk; Risk Factors; Russia; Spain; Turkey; Young Adult
Издатель
  • Public Library of Science
Тип документа
  • journal article
Тип лицензии Creative Commons
  • CC
Правовой статус документа
  • Свободная лицензия
Источник
  • scopus